Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues

Fig. 2

A Differential analysis of quantitative proteomic data generated from FFPE tissues collected pre-neoadjuvant chemotherapy (NACT) treatment from HGSOC patients with residual (R1, n = 6) or no/microscopic residual (R0, n = 14) disease at interval debulking surgery. Differential analyses of pre-NACT treated tissue revealed 140 proteins as significantly altered between these patient populations (LIMMA p-value ≤ 0.05). “R0” = none or microscopic, “R1” = macroscopic, i.e. < 1 cm disease

Back to article page

Clinical Proteomics

ISSN: 1559-0275